Form D · Pharmaceuticals
TheraVasc Inc.
Cleveland, OH · CIK 0001479295
Offering snapshot reported Mar 18, 2014 · SEC filing
- Reported sold
- $350K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 10, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2014 | Initial | $350,000 | No comparison | 1 | SEC filing |
| Nov 15, 2013 | Initial | $172,501 | No comparison | 10 | SEC filing |
| Sep 27, 2010 | Initial | $1,836,996 | No comparison | 20 | SEC filing |
| Dec 28, 2009 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-213791
Source: Form D, filed Mar 18, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kyle Chan | Director |
| Anthony Giordano | Director, Executive |
| John Huston | Director |
| Susan Luria | Director |
| William Stuart | Director |
| Stewart William | Director |
| John Zak | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10000 Cedar Avenue Gcic2 Ms#1
Cleveland, OH, 44106
Cleveland, OH, 44106